HealthEquity Inc.
Last updated September 27, 2026
Organization details
- Legal name
- HealthEquity Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- HQY
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001428336
Board of directors
-
Adrian T. Dillon · DirectorSince 2023
-
Debra Charlotte McCowan · DirectorSince 2023
-
Evelyn S. Dilsaver · DirectorSince 2023
-
Frank Corvino · DirectorSince 2023
-
Gayle Furgurson Wellborn · DirectorSince 2023
-
Ian Sacks · DirectorSince 2023
-
Jon Kessler · Director · PRESIDENT AND CEOSince 2023
-
Paul Black · DirectorSince 2023
-
Rajesh Natarajan · DirectorSince 2023
-
Robert W. Selander · DirectorSince 2023
-
Stephen Neeleman · Director · FOUNDER AND VICE CHAIRMANSince 2023
-
Stuart B. Parker · DirectorSince 2023
Chief executives
Jon Kessler
· PRESIDENT AND CEO
Dates unknown
Board connections
3 of this board's directors also sit on 4 other boards.
- via Rajesh Natarajan
- via Stuart B. Parker
- via Evelyn S. Dilsaver
- via Evelyn S. Dilsaver
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2024 | Stephen Neeleman Director, Officer (FOUNDER AND VICE CHAIRMAN) | Grant or award | +10,976 | — | — |
| Mar 27, 2024 | Jon Kessler Director, Officer (PRESIDENT AND CEO) | Grant or award | +103,806 | — | — |
| Mar 27, 2024 | Ladd Delano Officer (EVP, GC & CORPORATE SECRETARY) | Grant or award | +12,544 | — | — |
| Mar 27, 2024 | Rosner Elimelech Officer (EVP, CHIEF TECHNOLOGY OFFICER) | Grant or award | +18,816 | — | — |
| Mar 27, 2024 | Lucania James M Officer (EVP & CFO) | Grant or award | +21,952 | — | — |
| Mar 27, 2024 | Aissi Slim Officer (EVP, CHIEF SECURITY OFFICER) | Grant or award | +37,632 | — | — |
| Mar 27, 2024 | Stephen Neeleman Director, Officer (FOUNDER AND VICE CHAIRMAN) | Grant or award | +15,970 | — | — |
| Mar 27, 2024 | Ladd Delano Officer (EVP, GC & CORPORATE SECRETARY) | Grant or award | +11,711 | — | — |
| Mar 26, 2024 | Evelyn S. Dilsaver Director | Option exercise | +25,000 | $14.00 | $350,000 |
| Mar 26, 2024 | Evelyn S. Dilsaver Director | Option exercise | +7,500 | $14.00 | $105,000 |
| Mar 26, 2024 | Evelyn S. Dilsaver Director | Open-market sale | −32,500 | $79.29 | $2,576,925 |
| Mar 22, 2024 | Jon Kessler Director, Officer (PRESIDENT AND CEO) | Option exercise | +60,000 | $14.00 | $840,000 |
| Mar 22, 2024 | Jon Kessler Director, Officer (PRESIDENT AND CEO) | Open-market sale | −33,765 | $79.81 | $2,694,785 |
| Dec 19, 2023 | Ian Sacks FORMER DIRECTOR | Option exercise | +15,000 | $21.27 | $319,050 |
| Dec 19, 2023 | Ian Sacks FORMER DIRECTOR | Option exercise | +15,000 | $14.00 | $210,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.